| Date Checked | 2026-02-19 22:16:30 |
|---|
| Graham Number | (PB)nan vs (PE)0.00 |
|---|
| Over / Under Value Percentage | 0.00% vs 0.00% |
|---|
| Dividend Yield | 0.00% |
|---|
| Dividend Date | None |
|---|
| Symbol | SDGR |
|---|
| AssetType | Common Stock |
|---|
| Name | Schrodinger Inc |
|---|
| Description | Schrodinger Inc. (SDGR) is a pioneering leader in computational drug design, utilizing its advanced physics-based software platform to streamline the discovery and optimization of novel molecules across the pharmaceutical and materials science domains. Headquartered in New York, the company employs cutting-edge computational methodologies that not only expedite drug development but also significantly lower the costs associated with bringing innovative therapeutics to market. By enhancing the research and development capabilities of biotech and pharmaceutical organizations, Schrodinger has positioned itself as an essential partner in addressing the complex challenges of drug discovery, making it a compelling prospect for institutional investors. |
|---|
| CIK | 1490978 |
|---|
| Exchange | NASDAQ |
|---|
| Currency | USD |
|---|
| Country | USA |
|---|
| Sector | HEALTHCARE |
|---|
| Industry | HEALTH INFORMATION SERVICES |
|---|
| Address | 1540 BROADWAY, NEW YORK, NY, UNITED STATES, 10036 |
|---|
| OfficialSite | https://www.schrodinger.com |
|---|
| FiscalYearEnd | December |
|---|
| LatestQuarter | 2025-09-30 |
|---|
| MarketCapitalization | 1370900000 |
|---|
| EBITDA | -164102000 |
|---|
| PERatio | 0 |
|---|
| PEGRatio | None |
|---|
| BookValue | 4.364 |
|---|
| DividendPerShare | None |
|---|
| EPS | -2.4 |
|---|
| RevenuePerShareTTM | 3.508 |
|---|
| ProfitMargin | -0.685 |
|---|
| OperatingMarginTTM | -0.846 |
|---|
| ReturnOnAssetsTTM | -0.161 |
|---|
| ReturnOnEquityTTM | -0.457 |
|---|
| RevenueTTM | 256951000 |
|---|
| GrossProfitTTM | 149451000 |
|---|
| DilutedEPSTTM | -2.4 |
|---|
| QuarterlyEarningsGrowthYOY | 0 |
|---|
| QuarterlyRevenueGrowthYOY | 0.539 |
|---|
| AnalystTargetPrice | 25 |
|---|
| AnalystRatingStrongBuy | 0 |
|---|
| AnalystRatingBuy | 7 |
|---|
| AnalystRatingHold | 2 |
|---|
| AnalystRatingSell | 0 |
|---|
| AnalystRatingStrongSell | 0 |
|---|
| TrailingPE | - |
|---|
| ForwardPE | - |
|---|
| PriceToSalesRatioTTM | 5.34 |
|---|
| PriceToBookRatio | 4.266 |
|---|
| EVToRevenue | 4.246 |
|---|
| EVToEBITDA | -10.82 |
|---|
| Beta | 1.54 |
|---|
| 52WeekHigh | 28.47 |
|---|
| 52WeekLow | 15.99 |
|---|
| 50DayMovingAverage | 18.3 |
|---|
| 200DayMovingAverage | 20.57 |
|---|
| SharesOutstanding | 64501000 |
|---|
| SharesFloat | 57612000 |
|---|
| PercentInsiders | 2.582 |
|---|
| PercentInstitutions | 108.683 |
|---|
| ExDividendDate | None |
|---|
| dateChecked | 2026-02-19 22:16:30 |
|---|
| fresh | 1 |
|---|